borderline significantp = 0.07
When used as a continuous variable, the cancer pERK score emerged as a borderline significant predictor for RFS ( p = 0.07).
When used as a continuous variable, the cancer pERK score emerged as a borderline significant predictor for RFS ( p = 0.07).
In the patients not receiving adjuvant treatment, the cancer phospho-ERK score did not emerge as a significant predictor for RFS (5-year-RFS: high score: 76.2%; low score: 88.9%; p = 0.23) although a weak trend in favour of low scores was noted (Figure 5C ).
This effect is highly significant for high-risk patients receiving postoperative chemotherapy, but not for high-risk patients, who do not receive such therapy.